Close Menu

Making Changes

Patent reform could be happening soon, writes Kevin Noonan at Patent Docs. At a meeting held by BIO, Joseph Matal, the Republican general counsel for the Senate judiciary committee, says the Senate will "reach a deal" on the patent reform bill and that the House of Representatives will then pass that bill this year or early next year. According to Noonan, Matal gave the odds as 70 to 80 percent and that the bill will be largely similar to S. 515.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.